Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1994 1
1996 1
2000 4
2001 3
2003 3
2004 2
2005 5
2006 5
2007 1
2008 2
2009 5
2010 2
2011 3
2012 2
2013 1
2014 5
2016 3
2017 4
2018 3
2019 4
2020 5
2021 5
2022 5
2023 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial.
van der Windt LI, Klumper J, Duijnhoven RG, Kok M, Ris-Stalpers C, de Boer MA, van Kaam AH, Pajkrt E, Mol BW, Walker KF, McAuliffe FM, van der Post JA, Roos C, Oudijk MA; APOSTEL 8 Study Group. van der Windt LI, et al. Lancet. 2025 Mar 22;405(10483):1004-1013. doi: 10.1016/S0140-6736(25)00295-8. Epub 2025 Mar 3. Lancet. 2025. PMID: 40049187 Clinical Trial.
FINDINGS: Between Dec 4, 2017, and July 24, 2023, a total of 755 participants were randomly assigned, of whom 752 were included in the intention-to-treat analysis (atosiban n=375, placebo n=377). The primary outcome occurred in 37 (8%) of 449 infants in the atosiban …
FINDINGS: Between Dec 4, 2017, and July 24, 2023, a total of 755 participants were randomly assigned, of whom 752 were included in the inten …
Atosiban improves the outcome of embryo transfer. A systematic review and meta-analysis of randomized and non-randomized trials.
Schwarze JE, Crosby J, Mackenna A. Schwarze JE, et al. JBRA Assist Reprod. 2020 Oct 6;24(4):421-427. doi: 10.5935/1518-0557.20200016. JBRA Assist Reprod. 2020. PMID: 32401462 Free PMC article.
OBJECTIVE: To estimate the effectiveness of Atosiban in improving the outcome after embryo transfer. The effectiveness of embryo transfer per cycle is still relatively low. ...Search terms included Atosiban, embryo transfer. Study selection: We included studies that …
OBJECTIVE: To estimate the effectiveness of Atosiban in improving the outcome after embryo transfer. The effectiveness of embryo tran …
Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis.
Wang R, Huang H, Tan Y, Xia G. Wang R, et al. Front Endocrinol (Lausanne). 2023 Mar 23;14:1161707. doi: 10.3389/fendo.2023.1161707. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37033236 Free PMC article. Review.
This study aimed to explore the efficacy of atosiban on pregnancy outcomes of patients with RIF who received IVF-ET. METHODS: The research was designed using the PICOS format. ...Then trials comparing the efficacy of atosiban and control group on pregnancy outcomes …
This study aimed to explore the efficacy of atosiban on pregnancy outcomes of patients with RIF who received IVF-ET. METHODS: The res …
Usefulness of atosiban for tocolysis during external cephalic version: Systematic review and meta-analysis.
Riemma G, Schiattarella A, La Verde M, Cianci S, Savoia F, De Franciscis P, Cobellis L, Colacurci N, Morlando M. Riemma G, et al. Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:86-92. doi: 10.1016/j.ejogrb.2020.12.053. Epub 2020 Dec 31. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 33421816
CONCLUSION: The use of atosiban for tocolysis does not improve the rate of successful ECVs when compared to beta-agonists. However, atosiban was associated with a significantly lower incidence of side effects and comparable cesarean section rates....
CONCLUSION: The use of atosiban for tocolysis does not improve the rate of successful ECVs when compared to beta-agonists. However, …
Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects.
Wex J, Abou-Setta AM, Clerici G, Di Renzo GC. Wex J, et al. Eur J Obstet Gynecol Reprod Biol. 2011 Aug;157(2):128-35. doi: 10.1016/j.ejogrb.2011.04.009. Epub 2011 May 28. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21620558 Review.
A systematic literature review identified randomised controlled trials (RCTs) comparing atosiban with betamimetics. Meta-analysis of nine RCTs determined that atosiban and betamimetics had similar efficacy in delaying preterm birth by at least 48 h (p=0.910). Use of …
A systematic literature review identified randomised controlled trials (RCTs) comparing atosiban with betamimetics. Meta-analysis of …
Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
Wex J, Connolly M, Rath W. Wex J, et al. BMC Pregnancy Childbirth. 2009 Jun 19;9:23. doi: 10.1186/1471-2393-9-23. BMC Pregnancy Childbirth. 2009. PMID: 19538754 Free PMC article. Review.
In the probabilistic sensitivity analysis atosiban was cost saving versus both continuous and bolus fenoterol in 87%-100% of scenarios. ...Cost savings stem from the superior safety profile of atosiban....
In the probabilistic sensitivity analysis atosiban was cost saving versus both continuous and bolus fenoterol in 87%-100% of scenario …
Systematic review and meta-analysis of randomized controlled trials of atosiban versus nifedipine for inhibition of preterm labor.
Ali AA, Sayed AK, El Sherif L, Loutfi GO, Ahmed AMM, Mohamed HB, Anwar AT, Taha AS, Yahia RM, Elgebaly A, Abdel-Daim MM. Ali AA, et al. Int J Gynaecol Obstet. 2019 May;145(2):139-148. doi: 10.1002/ijgo.12793. Epub 2019 Mar 13. Int J Gynaecol Obstet. 2019. PMID: 30784056
BACKGROUND: Two tocolytic drugs-atosiban and nifedipine-are currently used for first-line treatment of preterm labor (PTL). OBJECTIVE: To compare the efficacy and safety of atosiban with nifedipine for PTL treatment. SEARCH STRATEGY: In May 2017, we searched PubMed, …
BACKGROUND: Two tocolytic drugs-atosiban and nifedipine-are currently used for first-line treatment of preterm labor (PTL). OBJECTIVE …
Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.
Coomarasamy A, Knox EM, Gee H, Song F, Khan KS. Coomarasamy A, et al. BJOG. 2003 Dec;110(12):1045-9. BJOG. 2003. PMID: 14664874 Review.
POPULATION: Six hundred and seventy-nine women recruited in nine randomised trials evaluating the effectiveness of nifedipine versus beta-agonists, and 852 women recruited in four trials of atosiban versus beta-agonists. There were no trials comparing nifedipine directly w …
POPULATION: Six hundred and seventy-nine women recruited in nine randomised trials evaluating the effectiveness of nifedipine versus beta-ag …
Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis.
van Winden TMS, Nijman TAJ, Kleinrouweler CE, Salim R, Kashanian M, Al-Omari WR, Pajkrt E, Mol BW, Oudijk MA, Roos C. van Winden TMS, et al. BMC Pregnancy Childbirth. 2022 Jul 15;22(1):567. doi: 10.1186/s12884-022-04854-1. BMC Pregnancy Childbirth. 2022. PMID: 35840927 Free PMC article.
The composite neonatal outcome occurred in 58/364 (16%) after nifedipine versus 69/359 (19%) after atosiban (OR 0.76, 95%CI 0.47-1.23). Perinatal death occurred in 14/392 (3.6%) after nifedipine versus 7/380 (1.8%) after atosiban (OR 2.0, 95%CI 0.80-5.1). Nifedipine …
The composite neonatal outcome occurred in 58/364 (16%) after nifedipine versus 69/359 (19%) after atosiban (OR 0.76, 95%CI 0.47-1.23 …
Interventions to optimize embryo transfer in women undergoing assisted conception: a comprehensive systematic review and meta-analyses.
Tyler B, Walford H, Tamblyn J, Keay SD, Mavrelos D, Yasmin E, Al Wattar BH. Tyler B, et al. Hum Reprod Update. 2022 Jun 30;28(4):480-500. doi: 10.1093/humupd/dmac009. Hum Reprod Update. 2022. PMID: 35325124 Free PMC article.
Other pharmacological add-ons also showed a beneficial effect including granulocyte colony-stimulating factor (G-CSF: n = 4, RR 1.774, 95% CI 1.252-2.512, I2 = 0), Atosiban (n = 7, RR 1.493, 95% CI 1.184-1.882, I2 = 68.27%) and hCG (n = 17, RR 1.232, 95% CI 1.099-1.382, I2 …
Other pharmacological add-ons also showed a beneficial effect including granulocyte colony-stimulating factor (G-CSF: n = 4, RR 1.774, 95% C …
73 results

Searches related to "atosiban"